Neuroimmune Foundation is a 501(c)(3) non-profit organization dedicated to
  • dramatically accelerating physician education of immunopsychiatric conditions
  • significantly improving outcomes for individuals impacted by these disorders through prompt diagnosis and insurance based care
  • providing meaningful support to families during their darkest days
  • catalyzing research at an unprecedented pace that will ultimately lead to lasting remission for all individuals impacted by these disorders.
Join us for a two day live conference in Palo Alto, California

Inflamma­tory Brain Disorders Conference 2024

The 2024 Inflammatory Brain Disorders Conference has been planned by the same individuals as the 2021, 2022, and 2023 Inflammatory Brain Disorders Conferences and is being hosted by our sister organization, Neuroimmune Institute, in partnership with Neuroimmune Foundation and with our Stanford and UCSF collaborators. Neuroimmune Institute was founded with the goal of rapidly advancing clinical medicine and research focused on immunopsychiatric, neuroimmune, and inflammatory brain conditions as well as autism.

While Neuroimmune Foundation and Neuroimmune Institute have a similar mission and collaboration, donations to Neuroimmune Foundation will not be used for Neuroimmune Institute activities nor vice versa.

Neuroimmune Institute offers continuing medical education on a broad array of topics beyond the scope of Neuroimmune Foundation’s mission.

What are Inflammatory Brain Disorders?

Individuals with inflammatory brain conditions often present with prominent neuropsychiatric symptoms that can be confusing for physicians and families alike. Our CME events feature nationally and internationally renowned experts skilled in diagnostic and therapeutic approaches who present a diverse range of emerging clinical and research challenges, insights, and advances in the field of inflammatory brain disorders. Presentations are carefully selected to familiarize attendees with rapidly developing research and to educate clinicians on the latest understanding of treatment options.

Check out our

Extensive Free Resources

Our extensive free resources for clinicians include Continuing Medical Education, access to top experts in the field through monthly case consultations, and quarterly compilation of relevant research. We provide clinicians the tools to confidently diagnose and treat immune-mediated neuropsychiatric illnesses and inflammatory brain conditions. Our Circle of Clinicians helps families to find a physician. Families are supported through therapist, physician, and researcher led webinars, local support meetings in locations around the world, a private Facebook group, and other resources.

Advocating on Behalf of Individuals with Neuroimmune and Inflammatory Brain Conditions

About us

Neuroimmune FoundationTogether with our supporters, Neuroimmune Foundation is making huge strides in educating clinicians on how to diagnose and treat immune and inflammation driven causes of psychiatric deteriorations. Visit our Impact Report pages to learn how our CME and related events help physicians gain confidence treating PANS, PANDAS, encephalitis, and related conditions.

Sign up for our newsletter

  • (All fields required)

Research Roundup

  • Researchers Uncover Mechanisms of Brexanolone and the Role of Inflammation in Post-partum Depression

    “The new finding is monumental in that it suggests that PPD is likely caused, at least in part, by inflammation.”

    UNC Health and UNC School of Medicine
    February 20, 2023

  • Evaluation of Brain-Body Health in Individuals with Common Neuropsychiatric Disorders

    JAMA Psychiatry
    April 26, 2023

  • Autoimmune Encephalitis Criteria in Clinical Practice

    Neurology: Clinical Practice
    April 25, 2023

  • Immunosuppressants Linked to Severe Reactions in People with Common Genetic Profile

    Stanford Medicine
    November 17, 2021

  • Neuroimmune Cell Signaling in Covid-19

    Frontiers in Immunology
    Research Topic 2022–2023

  • Further Understanding of Neuro-Immune Interactions in Allergy: Implications in Pathophysiology and Role in Disease Progression

    September 10, 2022

  • Tractography-based Versus Anatomical Landmark-Based Targeting in Valic Deep Brain Stimulation for Refractory Obsessive-Compulsive Disorder

    Molecular Psychiatry
    September 7, 2022

  • Elevated Biomarkers Associated with PASC Phenotype

    September 5, 2022

  • In Vivo Detection of Macromolecule Free Radicals in Mouse Sepsis-Associated Encephalopathy Using a New MRI and Immunospin Trapping Strategy

    September 1, 2022